Compounds and methods for selective inhibition of dipeptidyl peptidase-iv

作者: Juan Manuel Betancort , David Alan Campbell , David T. Winn

DOI:

关键词:

摘要: Compounds that selectively inhibit dipeptidyl peptidase-IV over closely related peptidases are those of Formula (I): as well pharmaceutically acceptable salts thereof, cyclic isomers prodrugs and solvates where all the variables defined herein. These compounds can be used, alone or in combination with other drugs, for treatment diabetes diseases.

参考文章(117)
Philip M. Sher, Benzo 1,3 dioxole derivatives ,(1994)
Asa Hedfors, Yi-Lin Li, Johan Malm, Ye Liu, Minsheng Zhang, Charlotta Mellin, Novel thyroid receptor ligands and method ,(1998)
William N. Washburn, Kathleen M. Poss, Philip M. Sher, Aryloxypropanolamine beta 3 adrenergic agonists ,(1995)
Scott A. Biller, Michael J. Sofia, Phosphorus-containing squalene synthetase inhibitors ,(1990)
Roger B. Ruggeri, Christian J. Mularski, Angel Guzman-Perez, Ernest S. Hamanaka, Ronald T. Wester, N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia ,(1999)
Masahiko Nishimoto, Mitsuyoshi Nakashima, Kazuo Umemura, Yasuhiko Ikeda, Kazunao Kondo, Yoshihiro Hiraga, Yasuhisa Yoshida, Pharmacokinetics and Safety of Z‐321, a Novel Specific Orally Active Prolyl Endopeptidase Inhibitor, in Healthy Male Volunteers The Journal of Clinical Pharmacology. ,vol. 39, pp. 462- 470 ,(1999) , 10.1177/009127009903900505
Edwin Bernard Villhauer, N-substituted 2-cyanopyrrolidines ,(1999)